A Multi-Center, Active-Controlled, Open-Label, Phase II Trial to Compare the Efficacy and Safety for Treatment of Autologous Chondrocytes Implantation with CartiLife versus Microfracture for Patient with Chondral Defects in the Knee

Trial Profile

A Multi-Center, Active-Controlled, Open-Label, Phase II Trial to Compare the Efficacy and Safety for Treatment of Autologous Chondrocytes Implantation with CartiLife versus Microfracture for Patient with Chondral Defects in the Knee

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Autologous chondrocyte implantation (Primary)
  • Indications Cartilage disorders
  • Focus Therapeutic Use
  • Sponsors MCTTBio
  • Most Recent Events

    • 12 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top